Analyse-Technique.net - Toutes les news de l'analyse technique


Categories


Tags

sanofi,aventis,q2,net,up,61,percent Sanofi-Aventis Q2 Net up 61 Percent
Sanofi-Aventis net up 61 percent, warns of hit to earnings from generic challenge to Lovenox Sanofi-Aventis - Food and Drug Administration - Lovenox - Novartis - Generic drug
2010-07-29 - ABC News